Market Insights Snapshot
Even Cannabis Company’s August 2026 mix concentrated 92.84% of sales in Edible with the remaining 7.16% in Flower, while Edible declined 94.62% year over year and 60.43% month over month versus Flower’s 80.06% YoY drop and 83.95% MoM contraction. The brand-level average price fell 6.25% YoY to $14.30 as Edible averaged 13.66 and Flower averaged 36.00, implying a portfolio tilt toward lower-priced units alongside category-level volume pressure; the pattern indicates a defensive consolidation around Edible in Ontario that preserved share mix but not velocity.
With Edible at 92.84% share despite a 60.43% MoM slide, the mix stability alongside outsized declines suggests limited new-buyer inflow and reliance on a shrinking core, while Flower’s 83.95% MoM drop off a smaller 7.16% base signals de-prioritization rather than a calibrated premium trade-up. Given a 94.62% YoY fall in Edible against an 80.06% YoY decline in Flower, the steeper pullback where the brand is most exposed points to positioning that is over-indexed to low-price, low-loyalty Edible occasions in Ontario, implying the need to rebalance toward fewer SKUs at a tighter price band to stabilize repeat purchase.
Competitive Landscape
Even Cannabis Company ranks #37 in ON Edible in August 2026, a 13-place YoY drop from #24, and an 8-place decline from #29 in May 2026, while sitting 13 spots below its August 2025 peak at #24; meanwhile, Spinach held #1 YoY with sales up 6.5% and Olli advanced from #7 to #5 on 80.2% sales growth, indicating Even Cannabis Company is ceding relative share as faster-rising peers consolidate top-10 positions; with No Future improving from #5 to #4 alongside 69.0% YoY sales growth, the directional gap versus Even Cannabis Company’s slide from #29 to #37 over the last three months implies the brand’s trajectory is downward unless assortment or pricing resets alter its rank momentum.

Notable Products
Gary Satan (3.5g) posted the steepest decline in August 2026 at -84% MoM while sliding to rank 4, signaling Flower is losing traction against Edible leaders. CBD Mango Lemonade Gummies 30-Pack (750mg CBD) fell -69% MoM yet held rank 1, and Biggies Cherry Cola Live Resin Soft Chews 4-Pack (10mg) dropped -34% MoM at rank 2, with CBD Blue Raspberry Lemonade Fast Acting Gummies 50-Pack (1500mg CBD) at -34% MoM in rank 3. Three of the top four SKUs are Edibles, indicating concentration in ingestibles even as the top Edible declined alongside peers, and only one raw dollar anchor remains concentrated at roughly $2.4K in the category leader. The pattern implies Even Cannabis Company is consolidating around Edibles while de-prioritizing Flower, suggesting a near-term focus on CBD-heavy gummy formats over inhalables.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.







